JPH0158949B2 - - Google Patents
Info
- Publication number
- JPH0158949B2 JPH0158949B2 JP61006630A JP663086A JPH0158949B2 JP H0158949 B2 JPH0158949 B2 JP H0158949B2 JP 61006630 A JP61006630 A JP 61006630A JP 663086 A JP663086 A JP 663086A JP H0158949 B2 JPH0158949 B2 JP H0158949B2
- Authority
- JP
- Japan
- Prior art keywords
- plasmid
- dna
- bacterial
- nrrl
- pro1601
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000013612 plasmid Substances 0.000 claims description 222
- 108020004414 DNA Proteins 0.000 claims description 130
- 230000001580 bacterial effect Effects 0.000 claims description 67
- 238000000034 method Methods 0.000 claims description 51
- 241000894006 Bacteria Species 0.000 claims description 42
- 239000012634 fragment Substances 0.000 claims description 41
- 238000010367 cloning Methods 0.000 claims description 37
- 229960003669 carbenicillin Drugs 0.000 claims description 31
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 claims description 31
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 26
- 230000003115 biocidal effect Effects 0.000 claims description 19
- 230000009466 transformation Effects 0.000 claims description 17
- 102000053602 DNA Human genes 0.000 claims description 16
- 230000008569 process Effects 0.000 claims description 16
- 101100112724 Prochlorococcus marinus (strain SARG / CCMP1375 / SS120) ccsB gene Proteins 0.000 claims description 12
- 238000001727 in vivo Methods 0.000 claims description 10
- 230000010076 replication Effects 0.000 claims description 8
- 230000021615 conjugation Effects 0.000 claims description 7
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 229940088710 antibiotic agent Drugs 0.000 claims description 6
- 238000003776 cleavage reaction Methods 0.000 claims description 5
- 230000007017 scission Effects 0.000 claims description 5
- 239000003550 marker Substances 0.000 claims description 4
- 230000026683 transduction Effects 0.000 claims description 3
- 238000010361 transduction Methods 0.000 claims description 3
- 108010042407 Endonucleases Proteins 0.000 claims description 2
- 102000004533 Endonucleases Human genes 0.000 claims description 2
- 101100300704 Prochlorococcus marinus (strain SARG / CCMP1375 / SS120) queF gene Proteins 0.000 claims 2
- 230000032823 cell division Effects 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 description 33
- 108091008146 restriction endonucleases Proteins 0.000 description 26
- 238000002474 experimental method Methods 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 19
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 16
- 229940024606 amino acid Drugs 0.000 description 15
- 150000001413 amino acids Chemical class 0.000 description 15
- 239000004098 Tetracycline Substances 0.000 description 14
- 229960002180 tetracycline Drugs 0.000 description 14
- 229930101283 tetracycline Natural products 0.000 description 14
- 235000019364 tetracycline Nutrition 0.000 description 14
- 150000003522 tetracyclines Chemical class 0.000 description 14
- 101100407030 Arabidopsis thaliana PAO2 gene Proteins 0.000 description 13
- 241000588724 Escherichia coli Species 0.000 description 13
- 230000012010 growth Effects 0.000 description 12
- 238000012423 maintenance Methods 0.000 description 11
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 10
- 108020004511 Recombinant DNA Proteins 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 229960000310 isoleucine Drugs 0.000 description 10
- 229960004295 valine Drugs 0.000 description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 9
- 239000013611 chromosomal DNA Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 229960004452 methionine Drugs 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 229930182844 L-isoleucine Natural products 0.000 description 7
- 230000010310 bacterial transformation Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000002503 metabolic effect Effects 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 5
- 229930195722 L-methionine Natural products 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 230000017105 transposition Effects 0.000 description 5
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 4
- 230000002759 chromosomal effect Effects 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000004474 valine Substances 0.000 description 4
- 241000589776 Pseudomonas putida Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000000721 bacterilogical effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 241000557626 Corvus corax Species 0.000 description 2
- 238000012270 DNA recombination Methods 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 150000003212 purines Chemical class 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 238000010188 recombinant method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 238000005549 size reduction Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000589149 Azotobacter vinelandii Species 0.000 description 1
- 108700003860 Bacterial Genes Proteins 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000606766 Haemophilus parainfluenzae Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001464937 Neisseria perflava Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- ITJLNEXJUADEMK-UHFFFAOYSA-N Shirin Natural products CCC(C)(O)c1c(Cl)c(OC)c(C)c2OC(=O)c3c(C)c(Cl)c(O)c(Cl)c3Oc12 ITJLNEXJUADEMK-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000030414 genetic transfer Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/12—Methionine; Cysteine; Cystine
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US147563 | 1980-05-08 | ||
| US06/147,563 US4374200A (en) | 1980-05-08 | 1980-05-08 | Broad host range small plasmid rings as cloning vehicles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61234784A JPS61234784A (ja) | 1986-10-20 |
| JPH0158949B2 true JPH0158949B2 (en, 2012) | 1989-12-14 |
Family
ID=22522070
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13943180A Granted JPS572299A (en) | 1980-05-08 | 1980-10-07 | Wide range host plasmid ring as cloning vector |
| JP61006630A Granted JPS61234784A (ja) | 1980-05-08 | 1986-01-17 | デオキシリボ核酸プラスミドをインビボの細菌宿主に輸送する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13943180A Granted JPS572299A (en) | 1980-05-08 | 1980-10-07 | Wide range host plasmid ring as cloning vector |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4374200A (en, 2012) |
| EP (1) | EP0039743A3 (en, 2012) |
| JP (2) | JPS572299A (en, 2012) |
| AU (1) | AU538600B2 (en, 2012) |
| CA (1) | CA1150169A (en, 2012) |
| DE (1) | DE39743T1 (en, 2012) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4508827A (en) * | 1980-05-08 | 1985-04-02 | Microlife Technics, Inc. | Molecular cloning vectors for use in gram-negative bacteria |
| US4508823A (en) * | 1980-05-08 | 1985-04-02 | Microlife Technics, Inc. | Gene splicing method and products produced therefrom |
| US4508824A (en) * | 1980-05-08 | 1985-04-02 | Microlife Technics, Inc. | Pseudomonas degradation of hydrocarbons |
| JPS58893A (ja) * | 1981-06-25 | 1983-01-06 | Ajinomoto Co Inc | 発酵法によるｌ−イソロイシンの製造法 |
| US4654307A (en) * | 1983-02-17 | 1987-03-31 | The Research Foundation Of State University Of New York | Novel bacteria containing a plasmid having a tRNA code |
| US4567141A (en) * | 1983-04-25 | 1986-01-28 | Microlife Technics, Inc. | Plasmid vectors including Tn904 |
| US4593003A (en) * | 1983-05-19 | 1986-06-03 | Microlife Technics, Inc. | Bacterial method and compositions for isoprenoid degradation |
| EP0185005B1 (en) | 1984-12-10 | 1992-01-22 | Monsanto Company | Insertion of the bacillus thuringiensis crystal protein gene into plant-colonizing microorganisms and their use |
| US4695455A (en) * | 1985-01-22 | 1987-09-22 | Mycogen Corporation | Cellular encapsulation of pesticides produced by expression of heterologous genes |
| EP0200708B1 (en) * | 1985-04-30 | 1992-12-30 | Monsanto Company | Plant-colonizing microorganisms containing the toxin gene of b. thuringiensis as a chromosomal insertion |
| JPS63104406U (en, 2012) * | 1986-12-26 | 1988-07-06 | ||
| AU2007352618B2 (en) | 2007-05-02 | 2013-07-18 | Boehringer Ingelheim Animal Health USA Inc. | DNA plasmids having improved expression and stability |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237224A (en) * | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
-
1980
- 1980-05-08 US US06/147,563 patent/US4374200A/en not_active Expired - Lifetime
- 1980-06-18 AU AU59374/80A patent/AU538600B2/en not_active Ceased
- 1980-06-27 EP EP80103658A patent/EP0039743A3/en not_active Withdrawn
- 1980-06-27 DE DE198080103658T patent/DE39743T1/de active Pending
- 1980-06-30 CA CA000355182A patent/CA1150169A/en not_active Expired
- 1980-10-07 JP JP13943180A patent/JPS572299A/ja active Granted
-
1986
- 1986-01-17 JP JP61006630A patent/JPS61234784A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6359677B2 (en, 2012) | 1988-11-21 |
| AU538600B2 (en) | 1984-08-23 |
| JPS572299A (en) | 1982-01-07 |
| US4374200A (en) | 1983-02-15 |
| EP0039743A2 (en) | 1981-11-18 |
| EP0039743A3 (en) | 1982-10-27 |
| JPS61234784A (ja) | 1986-10-20 |
| AU5937480A (en) | 1981-11-12 |
| CA1150169A (en) | 1983-07-19 |
| DE39743T1 (de) | 1983-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | A semisynthetic organism engineered for the stable expansion of the genetic alphabet | |
| Camacho et al. | Conjugal transfer of the virulence plasmid of Salmonella enterica is regulated by the leucine‐responsive regulatory protein and DNA adenine methylation | |
| EP0332488B1 (fr) | Procédé pour l'intégration d'un gène choisi sur le chromosome d'une bactérie et bactérie obtenue par ledit procédé | |
| Hulton et al. | Histone-like protein H1 (H-NS), DNA supercoiling, and gene expression in bacteria | |
| SANTAMARiA et al. | Characterization of an endogenous plasmid and development of cloning vectors and a transformation system in Brevibacterium lactofermentum | |
| Cameron et al. | DNA supercoiling is differentially regulated by environmental factors and FIS in Escherichia coli and Salmonella enterica | |
| Ishikawa et al. | A new simple method for introducing an unmarked mutation into a large gene of non-competent Gram-negative bacteria by FLP/FRT recombination | |
| Gralton et al. | Directed introduction of DNA cleavage sites to produce a high-resolution genetic and physical map of the Acinetobacter sp. strain ADP1 (BD413UE) chromosome | |
| JPH0158949B2 (en, 2012) | ||
| Guiney Jr | Promiscuous transfer of drug resistance in gram-negative bacteria | |
| Jacoby et al. | Properties of IncP-2 plasmids of Pseudomonas spp | |
| Lang et al. | Characterization of Acr2, an H-NS-like protein encoded on A/C2-type plasmids | |
| Henkin et al. | Snyder and Champness molecular genetics of bacteria | |
| Fonseca et al. | Random transposon mutagenesis identifies genes essential for transformation in Methanococcus maripaludis | |
| AmbrožKičK et al. | Escherichia coli ColV plasmid pRK100: genetic organization, stability and conjugal transfer | |
| Lo Sciuto et al. | Generation of stable and unmarked conditional mutants in Pseudomonas aeruginosa | |
| FR2559781A1 (fr) | Nouveau vecteur plasmidique hybride de e. coli conferant le pouvoir de faire fermenter le saccharose et son procede de preparation | |
| US4376164A (en) | Process for preparing broad host range small plasmid rings as cloning vehicles | |
| Foster et al. | Genetic Analysis of Deletions of R1001 that are Both Transfer-deficient and Tetracycline-sensitive | |
| US4418194A (en) | DNA Fragments for forming plasmids | |
| Yon et al. | Cloning and sequencing of the gerD gene of Bacillus subtilis | |
| JPS6254473B2 (en, 2012) | ||
| Perez-Casal et al. | Novel incompatibility and partition loci for the REPI replication region of plasmid ColV-K30 | |
| Smith et al. | R-plasmid-mediated chromosome mobilization in Bordetella pertussis | |
| JP2518051B2 (ja) | ＡｃｃＩ制限エンドヌクレア―ゼの製造方法 |